Global Oncology/Anti-Cancer Drugs Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Therapeutic Modalities;

Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Segmented by Cancer Types;

Blood Cancer (Leukaemia), Breast Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Skin Cancer and Other Cancers.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn182018413 Published Date: December, 2022 Updated Date: January, 2023

Introduction

Global Oncology/Anti-Cancer Drugs Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 67.6
2019 77.7
2020 89.7
2021 91.6
2022 93.4
2023 111.7
2024 115.8
2025 117.7
2026 125.1
2027 134.9
2028 149.7

In the year 2021, the Global Oncology/Anti-Cancer Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Therapeutic Modalities
    2. Market Snapshot, By Cancer Types
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Oncology/Anti-Cancer Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising incidence and prevalence of various cancer types
        2. Growing importance of biological and targeted drug therapies
        3. Increasing funding and aid from public and private sector
      2. Restraints
        1. High cost of drug development and threat of failure
        2. Adverse effects of cancer drug therapy
      3. Opportunities
        1. Advancement of anti-cancer drugs research
        2. Healthcare and medical awareness
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Oncology/Anti-Cancer Drugs Market, By Therapeutic Modalities, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Chemotherapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Targeted Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Immunotherapy (Biologic Therapy)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Hormonal Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Oncology/Anti-Cancer Drugs Market, By Cancer Types, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Blood Cancer (Leukaemia)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Breast Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Gastrointestinal Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Respiratory/Lung Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Skin Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        6. Other Cancers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Oncology/Anti-Cancer Drugs Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Modalities, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Cancer Types, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Amgen Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. AstraZeneca PLC.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Roche Diagnostics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. GlaxoSmithKline PLC
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Merck & Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Novartis AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. AbbVie Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Sanofi
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. EIMC United Pharmaceuticals (EUP)
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Actavis plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Oncology Cancer Drugs
Global Oncology/Cancer Drugs Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Oncology/Cancer Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Healthcare IT Operating Room Management
Global Operating Room Management Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Operating Room Management Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Ophthalmic Refractometer
Global Ophthalmic Refractometer Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Ophthalmic Refractometer Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Ophthalmic Viscosurgical Devices (OVD)
Global Ophthalmic Viscosurgical Devices (OVD) Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Ophthalmic Viscosurgical Devices (OVD) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...